BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li YN, Xie B, Zhang Y, He MH, Xing Y, Mu DM, Wang H, Guo R. Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023). World J Gastroenterol 2023; 29(40): 5593-5617 [PMID: 37970478 DOI: 10.3748/wjg.v29.i40.5593]
URL: https://www.wjgnet.com/1007-9327/full/v29/i40/5593.htm
Number Citing Articles
1
Sanjeevram Dhandapani, Abdus Samad, Ying Liu, Rongbo Wang, Sri Renukadevi Balusamy, Haribalan Perumalsamy, Yeon-Ju Kim. Coprisin/Compound K Conjugated Gold Nanoparticles Induced Cell Death through Apoptosis and Ferroptosis Pathway in Adenocarcinoma Gastric CellsACS Omega 2024; 9(24): 25932 doi: 10.1021/acsomega.4c00554
2
Guodong Liang, Yuehan Ma, Ping Deng, Shufeng Li, Chunyan He, Haihang He, Hairui Liu, Yunda Fan, Ze Li. Role of cell-based therapies in digestive disorders: Obstacles and opportunitiesRegenerative Therapy 2025; 29: 1 doi: 10.1016/j.reth.2025.02.009
3
John K Triantafillidis, Manousos M Konstadoulakis, Apostolos E Papalois. Immunotherapy of gastric cancer: Present status and future perspectivesWorld Journal of Gastroenterology 2024; 30(8): 779-793 doi: 10.3748/wjg.v30.i8.779
4
Kavita A Iyer, Rumiana Tenchov, Julian M Ivanov, Qiongqiong Angela Zhou. Emerging Concepts in Immuno-Oncology: Insights from Natural Language Processing-Driven Co-Occurrence AnalysisACS Omega 2025;  doi: 10.1021/acsomega.5c00693
5
Grigorios Christodoulidis, Konstantinos Eleftherios Koumarelas, Marina Nektaria Kouliou. Revolutionizing gastric cancer treatment: The potential of immunotherapyWorld Journal of Gastroenterology 2024; 30(4): 286-289 doi: 10.3748/wjg.v30.i4.286
6
Yasin Kutlu, Shute Ailia Dae, Feride Yilmaz, Dilek Erdem, Mehmet Ali Nahit Sendur, Sinem Akbas, Elif Senocak Tasci, Onur Bas, Faysal Dane, Abdullah Sakin, Ali Osman Kaya, Musa Baris Aykan, Yakup Ergun, Sedat Biter, Umut Disel, Mustafa Korkmaz, Fatih Selcukbiricik, Fatih Kose, Omer Fatih Olmez, Ahmet Bilici, Gokhan Demir, Suayib Yalcin. Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) StudyCancers 2024; 16(12): 2251 doi: 10.3390/cancers16122251
7
Margherita Ratti, Elena Orlandi, Ilaria Toscani, Stefano Vecchia, Elisa Anselmi, Jens Claus Hahne, Michele Ghidini, Chiara Citterio. Emerging Therapeutic Targets and Future Directions in Advanced Gastric Cancer: A Comprehensive ReviewCancers 2024; 16(15): 2692 doi: 10.3390/cancers16152692
8
Qian-Cheng Du, Xin-Yu Wang, Hua Yu. Gastric cancer immunotherapy: A scientometric and clinical trial reviewWorld Journal of Gastroenterology 2024; 30(2): 196-198 doi: 10.3748/wjg.v30.i2.196
9
Xiuyu Chu, Xun Li, Yang Li, Yu Zhang, Xinliang Gu, Xianjuan Shen, Shaoqing Ju. Exploring the diagnostic potential of serum 5′tRF-Lys as a novel gastric cancer biomarkerClinical Biochemistry 2025; 138: 110966 doi: 10.1016/j.clinbiochem.2025.110966
10
Yuwei Sun, Wenyang Nie, Zhikai Xiahou, Xiaojing Wang, Wenjia Liu, Zongkai Liu, Zhiheng Lin, Zhaidong Liu. Integrative single-cell and spatial transcriptomics uncover ELK4-mediated mechanisms in NDUFAB1+ tumor cells driving gastric cancer progression, metabolic reprogramming, and immune evasionFrontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1591123
11
Shi-Yan Yan, Jian-Gao Fan. Application of immune checkpoint inhibitors and microsatellite instability in gastric cancerWorld Journal of Gastroenterology 2024; 30(21): 2734-2739 doi: 10.3748/wjg.v30.i21.2734